Epioxa is a small molecule drug delivered as an eye drop that strengthens the cornea.

Keratoconus is a progressive eye condition that affects the shape and clarity of the cornea, often beginning in the teenage ...

This observation has long remained in my thoughts when working with patients with keratoconus. Even after trying several types of ICRS devices, I was always aware that I could not provide the truly ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Epion Therapeutics (Epion) announced the commencement of its Phase 3 Apricity trials for EpiSmart™, the company’s minimally-invasive keratoconus therapy. This marks ...

Please provide your email address to receive an email when new articles are posted on . Keratoconus is a personal area of interest. In this commentary, I will share a few of my current thoughts on the ...

On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Keratoconus pipeline constitutes 3+ key companies continuously working towards developing 3+ Keratoconus treatment ...

Two surgical procedures have been described for ICRS implantation: the mechanical method and the femtolaser method. The use of femtolaser for ICRS tunnel creation was widely accepted after FDA ...

DAVENPORT, Iowa (KWQC) - Keratoconus is a non-inflammatory eye condition in which the typically round dome-shaped cornea progressively thins and weakens causing the development of a cone-like bulge ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

Keratoconus, a progressive eye disorder that distorts vision, is increasingly being detected among Sri Lankans, including ...